SEMA3A and systemic sclerosis: Rimar D et al. showed that Sema3A expression is reduced in serum and regulatory T cells (Treg) from SSc patients compared to HC [53]; however, Romano E et al. did not replicate this finding, as they did not find differences in the serum and skin expression of Sema3A between HC and SSc patients [54].